SCHEMBL8034347

SCHEMBL8034347

CC(CCN1CCC(NS(C)(=O)=O)CC1)(C(=O)NCc1ccc(N)cc1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 4/20 0.42
TACR2 P21452 3/20 0.41
TACR1 P25103 3/20 0.41
KCNH2 Q12809 2/20 0.41
CACNA1I Q9P0X4 2/20 0.41
CCR2 P41597 1/20 0.38
HRH1 P35367 1/20 0.37
CCR3 P51677 1/20 0.37
SIGMAR1 Q99720 2/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2B Q13224 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
F2R P25116 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
P2RX7 Q99572 1/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL296022 0.94 TACR3 (0.43) TACR3TACR2TACR1KCNH2CACNA1I
SCHEMBL296032 0.92 TACR3 (0.46) TACR3TACR2TACR1KCNH2CACNA1I
SCHEMBL297584 0.91 TACR3 (0.43) TACR3TACR2TACR1KCNH2CACNA1I
SCHEMBL296164 0.90 PDE5A (0.42) TACR3TACR2TACR1KCNH2CACNA1I
SCHEMBL298428 0.90 TACR3 (0.45) TACR3TACR2TACR1KCNH2CACNA1I
SCHEMBL298155 0.89 DDR1 (0.43) TACR3TACR2TACR1KCNH2CACNA1I
SCHEMBL297799 0.89 TACR3 (0.49) TACR3TACR2TACR1KCNH2CACNA1I
SCHEMBL299660 0.88 TACR3 (0.44) TACR3TACR2TACR1KCNH2CACNA1I
SCHEMBL12943002 0.87 TACR3 (0.40) TACR3TACR2TACR1SIGMAR1P2RX7
SCHEMBL12943003 0.85 CCR2 (0.39) TACR3TACR2TACR1KCNH2CACNA1I

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009033995-A1 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-03-19 WO disclosed